Lisata Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Lisata Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Lisata Therapeutics Inc Strategy Report
- Understand Lisata Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Lisata Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
10 Aug 2022 | Cend Therapeutics Enters into Agreement with Roche | Partnership | - |
Cend Therapeutics Inc
Hoffmann–La Roche
|
26 Apr 2022 | Caladrius Biosciences and Cend Therapeutics Merge to Form Lisata Therapeutics | Merger |
Lisata Therapeutics Inc
|
Lisata Therapeutics Inc
Cend Therapeutics Inc
|
04 Jun 2021 | Caladrius Biosciences to Raise up to USD50 Million in Public Offering of Shares | Equity Offering | - |
Lisata Therapeutics Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer